Costas Evripides is the Managing Director and one of the founding members of Genesis Pharma. Mr Evripides holds an Athens University (ASOEE) Economics degree and an MBA from the London Business School. He started his managerial career in PepsiCo International as Assistant Country Manager for Greece and Cyprus (1979‐1983). Costas Evripides has a long experience and in‐depth knowledge of the pharmaceutical sector. In 1985 he assumed the position of Area Manager Mediterranean for Greece and Israel of Wellcome Foundation Ltd and in 1993 he led the founding of the Greek subsidiary Wellcome Hellas SA, assuming the position of President and Chief Executive Officer, until the company’s acquisition by Glaxo in 1995.
In 1997, together with Alex and Aris Jacovides, he founded the innovative pharmaceutical company GENESIS Pharma SA, the first company in Greece specializing in pharmaceutical biotechnology, at a time when the industry was in its early stages. GENESIS Pharma has long standing exclusive partnerships with major international biotechnology companies such as Alnylam, Amicus Therapeutics, Biogen, CSL Vifor, Incyte, PharmaMar, JAZZ Pharma and more recently Kyowa Kirin and Seagen.